Therefore, these results indicate a possible role for IQGAP1 in malignancy progression of ESCC and IQGAP1-siRNA can be used as a novel drug for therapeutic targeting of IQGAP1 in ESCC. The gene discussed is IQGAP1; the disease is esophageal squamous cell carcinoma.